Therapy of neurotic and pseudoneurotic symptoms with tofisopam.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006261:Headache / Q000188:drug therapy; D006801:Humans; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy*; D011569:Psychiatric Status Rating Scales
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; C012582:tofisopam